NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc., (OTCBB: GTHP) (OTCQB: GTHP), today announced that it has successfully completed third-party testing of the LuViva® Advanced Cervical Scan. This puts LuViva in compliance with Canadian Standards Association (CSA®) requirements which, while not required for marketing in Canada, are preferred by certain larger medical institutions. It also puts the company one step closer to applying the Edition 3 CE Mark to LuViva.
